Back to company

FORWARD PHARMA A/S: Financial statements 2021

CVR: 28865880

FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -10,812,930 and a net result of DKK -12,271,137 compared with DKK -42,201,691 the year before. Equity amounted to DKK 461,863,380. The solvency ratio was 82.3%. The company had 2 employees in the financial year.

Gross Profit
-10,812,930 kr.
Profit/Loss
-12,271,137 kr.
Equity
461,863,380 kr.
Total Assets
561,060,279 kr.
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--10.8 mio.-12.3 mio.461.9 mio.2
2020--7.8 mio.-42.2 mio.474.1 mio.2
2019--6 mio.-28.5 mio.515.9 mio.3
20180-7.6 mio.-54.3 mio.534.6 mio.3
20171.3 mia.-880.2 mio.89.4 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like FORWARD PHARMA A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

FORWARD PHARMA A/S: The 2020 annual report is outJun 2, 2021

FORWARD PHARMA A/S has published its annual report for 2020. Gross profit came to DKK -7,763,728, and the net result was DKK -42,201,691.

About FORWARD PHARMA A/S

FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005 and dissolved in 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees. In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity amounted to DKK 488,330,233.